Overview

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company's mission is to improve the lives of people living with certain underserved conditions through innovative clinical research. Axsome leverages its experience to develop and commercialize new treatment options that address significant unmet medical needs.

Therapeutic areas

Central Nervous System DisordersDepressionMigraineNarcolepsyAlzheimer's Disease Agitation

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Axsome Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Axsome Therapeutics, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.